Theme VIII – Refinement and Welfare

Coordinators

Thierry Decelle, Sanofi Pasteur, Marcy L'Etoile, France – IQ consortium
Mark Prescott, NC3Rs, London, UK
Joanne Zurlo, CAAT, Baltimore, MD, USA

VIII-1a Non-human primate use and welfare
Paul Honess, Bioculture Group, UK
Patricia V. Turner, University of Guelph, Canada

VIII-1b Non-human primate use and welfare
Jaco Bakker, BPRC, The Netherlands
Melanie Graham, University of Minnesota, USA

VIII-2a Best practice welfare approaches – Mouse
Robert Hubrecht, Universities Fed. Animal Welfare, UK
Joanne Zurlo, CAAT, USA

VIII-2b Best practice welfare approaches – Mouse
Michael Walker, University of Guelph, Canada
Hanno Würbel, University of Bern, Switzerland

VIII-3   Humane principles in experimental techniques and benefits of 3Rs
Jan-Bas Prins, FELASA, Leiden University, Medical Center, The Netherlands
Tim Sangster, Charles River Laboratories, UK

VIII-4   Avoidance of severe suffering
Anna Olsson, IBMC, Portugal
Mark Prescott, NC3Rs, UK

VIII-5   Culture of care
Jann Hau, University of Copenhagen, Denmark
Susanna Louhimies, DG ENV, EU Commission, Belgium

VIII-6   Transgenic animals – Approaches to reduction and refinement in the production and use of GM mice
Coenraad Hendriksen, Utrecht University, The Netherlands
Boris Jerchow, MDC Molecular Medicine, Germany